Remifentanil for tracheal tube tolerance: a case control study

Area of Science:

• Anesthesiology
• Critical Care Medicine
• Postoperative Care

Background:

• Tracheal intubation is common in major abdominal surgery.
• Maintaining patient comfort and spontaneous respiration post-operatively is crucial.
• Determining optimal sedative dosages for awake extubation is essential.

Purpose of the Study:

• To determine the minimum effective remifentanil dosage for tracheal tube tolerance.
• To evaluate patient comfort and respiratory parameters during awake extubation.
• To assess the safety and efficacy of low-dose remifentanil in postoperative patients.

Main Methods:

• Prospective study involving 40 postoperative patients undergoing major abdominal surgery.
• Remifentanil dosage was titrated downwards from 0.1 microg.kg(-1).min(-1) in 30-minute intervals.
• Comfort Scale Respiratory Response (CSRR), Ramsay Sedation Scale (RSS), Visual Analogue Scale (VAS), respiratory rate, and minute ventilation were monitored.

Main Results:

• 77.5% of patients achieved target tracheal tube tolerance (CSRR 2, RSS 2) at 0.025 microg.kg(-1).min(-1) remifentanil.
• 22.5% of patients required a slightly higher dose of 0.05 microg.kg(-1).min(-1).
• Adequate analgesia (VAS ≤ 30) was achieved in all participants.

Conclusions:

• Low-dose remifentanil (0.025-0.05 microg.kg(-1).min(-1)) is effective for tracheal tube tolerance.
• This dosage range supports awake and spontaneously breathing status post-abdominal surgery.
• Remifentanil offers a viable option for managing awake extubation in this patient population.